Intracavitary Hyperthermia and Intra-arterial Chemotherapy

  • Stephen C. Jacobs
Part of the Developments in Oncology book series (DION, volume 26)


Intra-arterial (IA) chemotherapy improves the therapeutic index of administered agents. This conference has addressed this issue in great depth, and I would like to comment only on the agents doxorubicin (ADR) and cis-diamminedichloroplatinum II (CDDP). ADR has been found to be more effective in the rabbit VX-2 tumor when given IA than IV.(1) ADR IA infusion of the dog limb results in greater normal tissue uptake of ADR than IV infusion.(2) Clinical IA infusions of ADR alone have shown promise for a number of tumors.(3,4) The long plasma half-life of ADR, however, would favor the IV use of this agent.(5)


Bladder Cancer Radical Cystectomy Superior Gluteal Artery Cystectomy Specimen Tional Cell Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Swistel AJ, Hancock CH, Bading JR, Leyland-Jones B, Raaf JH: Pharmacokinetics of Intra-arterial versus intravenous Adriamycin in the VX-2 tumor system. Surgical forum 34: 443–444, 1983.Google Scholar
  2. 2.
    Didolkar MS, Kanter PM, Baffi RR, Schwartz HS, Lopez R, Baez N: Comparison of regional versus systemic chemotherapy with Adriamycin. Ann Surg (187): 332–336, 1978.CrossRefGoogle Scholar
  3. 3.
    Kraybill WG, Harrison M, Sasaki T, Fletcher WS: Regional intraarterial infusion of Adriamycin in the treatment of cancer. Surg Gynec & Obstet (144): 335–338, 1977.Google Scholar
  4. 4.
    Nakazono M, Iwata S: Intra-arterial infusion as a preoperative chemotherapeutic treatment for bladder tumor. American Urological Association annual meeting, San Francisco, California, May 18–22, 1980.Google Scholar
  5. 5.
    Benjamin R.S., Riggs C.E., Jr., Bachur N.R.: Pharmacokinetics and metabolism of Adriamycin in man. Clin Pharmacol Ther (14): 592–600, 1973.PubMedGoogle Scholar
  6. 6.
    Stewart DJ, Benjamin RS, Zimmerman S, Caprioli RM, Wallace S, Chuang V, Calvo D III, Samuels M, Bonura J, Loo TL: Clinical Pharmacology of intra-arterial cis-diamminedicloroplatinum (II). Cancer Res (43): 917–920, 1983.Google Scholar
  7. 7.
    Carlson JA, Freedman RS, Wallace S, Chuang VP, Wharton JT, Rutledge FN: Intra-arterial cis-platinum in the management of squamous cellcarcinoma of the uterine cervix. Gynecol Oncol (12): 92–98, 1981.PubMedCrossRefGoogle Scholar
  8. 8.
    Cheng E, Watson RC, Fortner J, Kemeny N, Golbey R: Regional intraarterial infusion of cisplatin in primary liver cancer: A phase II trial. Proc Am Soc Clin Oncol (1): 179, 1982.Google Scholar
  9. 9.
    Baker S, Wheeler R, Meduec B, Keller J, Keyes J, Ensminger W: Outpatient intra-arterial chemotherapy in head and neck cancer patients using a totally implanted infusion system. Proc Am Soc Clin Oncol (11): 195, 1982.Google Scholar
  10. 10.
    Horiuchi M, Inuyama Y, Kohno N: Clinical pharmacology of intraarterial and intravenous cis-diamminedichloroplatinum (II). Proc XIII International Cancer Congress 13: 60, 1982.Google Scholar
  11. 11.
    Ajani JA, Burgess MA: Multiple squamous cell carcinoma treated with intra-arterial cisplatin in a patient with rheumatoid arthritis. Cancer Treatment Reports (66): 1987 - 1989, 1982.Google Scholar
  12. 12.
    Jaffe N, Knapp J, Chuang VP, Wallace S, Ayala A, Murray J, Cangir A, Wang A, Benjamin RS: Osteosarcoma: Intra-arterial treatment of the primary tumor with cis-diammine-dichloroplatinum II (CDP). Cancer (51): 402–407, 1983.Google Scholar
  13. 13.
    Calvo DB III, Patt YZ, Wallace S, Chuang VP, Benjamin RS, Pritchard JD, Hersh EM, Bodey GP Sr, Mavligit GM: Phase I-II trial of intraarterial cis-diammine dichloroplatinum (II) for regionally confined malignancy. Cancer (45): 1278–1283, 1980.Google Scholar
  14. 14.
    Stewart DJ, Wallace S, Feun L, Leavens M, Young SE, Handel S, Mavligit G, Benjamin RS: A Phase I study of intracarotid artery infusion of cis-diammine dichloroplatinum (II) in patients with recurrent malignant intracerebral tumors. Cancer Research (42): 2059–2062, 1982.Google Scholar
  15. 15.
    Pritchard JD, Mavligit GM, Benjamin RS, Patt YZ, Calvo DB, Hall SW, Bodby GP, Wallace S: Regression of regionally confined melanoma with intra-arterial cis-dichlorodiammine platinum (II). Cancer Treatment Rep 63.Google Scholar
  16. 16.
    Wallace S, Chuang VP, Samuels M, Johnson D: Transcatheter Intraarterial infusion of chemotherapy in advanced bladder cancer. Cancer (49): 640–645, 1982.Google Scholar
  17. 17.
    Dewey WC, Saparetto SA, Betten DA: Hyperthermic radiosensitization of synchronous Chinese hamster cells and relation between lethality and chromosomal aberrations. Radiation Res (76): 48 - 59, 1978.Google Scholar
  18. 18.
    Gerner EW: Thermotolerance in hyperthermia in cancer therapy. In Storm FK (ed) GK Hall, Boston, 1983, PP 141–162.Google Scholar
  19. 19.
    Song CW: Blood flow in tumors and normal tissues in hyperthermia in cancer therapy. In: Storm FK (ed) GK Hall, Boston, 1983, pp 187–206.Google Scholar
  20. 20.
    Herman TS, Baustian AM, Kundrat MA: Enhancement of hyperthermia induced lethality and modulation of Adriamycin cytotoxicity by cooling. Proc Am Assoc Can Res (22): 221, 1981.Google Scholar
  21. 21.
    Vig BK: Effect of hypothermia and hyperthermia on the induction of chromosome aberrations by Adriamycin in human leukocytes. Cancer Res (38): 550–555, 1978.Google Scholar
  22. 22.
    Hahn GM, Braun J, Har-Kedar I: Thermochemotherapy: Synergism between hyperthermia (42-43° C) and adriamycin (or bleomycin) in mammalian cell inactivation. Proc Natl Acad Sci USA (72): 937: 940, 1975.Google Scholar
  23. 23.
    Marmor JB: Interactions of hyperthermia and chemotherapy in animals. Cancer Res (39): 2269–2276, 1979.Google Scholar
  24. 24.
    Hahn GM: Potential for therapy of drugs and hyperthermia. Cancer Res (39): 2264–2268, 1979.Google Scholar
  25. 25.
    Meyn RE, Corry PM, Fletcher SE, Demetriades M: Thermal enhancement of DNA damage for mammalian cells treated with cis-diamminedichloroplatinum (II). Cancer Res (40): 1136–1139, 1980.Google Scholar
  26. 26.
    Fisher GA, Hahn GM: Enhancement of cis-platinum (II) diamminedichloride cytotoxicity by hyperthermia. Natl Cancer Inst Monogram (61): 255–257, 1982.Google Scholar
  27. 27.
    Brouwer J, Fichtinger-Schepman AM J, Van de Putte P, and Reedijk J: Influence of temperature on platinum binding to DNA, cell killing, and mutation induction in escherichia coli K-12 cells treated with cisdiamminedichloroplatinum (II). Cancer Res (42): 2416–2419, 1982.Google Scholar
  28. 28.
    Alberts DS, Peng YM, Chen HSG, Moon TE, Cetas TL, and Hoeschele JD: Therapeutic synergism of hyperthermia-cis-platinum in a mouse tumor model. J.N.C. I. (65): 455–46l, 1980.Google Scholar
  29. 29.
    Quebbman EJ, Skibba JL, Petroff RJ Jr: A technique for isolated hyperthermic liver perfusion. J Surg Oncol (in press).Google Scholar
  30. 30.
    Cavaliere R, Mondovi B, Moricca G, Monticelli G, Natali PG, Santori FS, DiFillippo F, Varenese A, Aloe L, Rossi-fanelli A: Regional perfusion hyperthermia. In: Storm FK (ed) Hyperthermia in cancer therapy. GK Hall, Boston, 1983, PP 369–399.Google Scholar
  31. 31.
    Hild P, Aigner K, Henneking K: Levels of cis-platinum in hyperthermic isolated perfusion. Anticancer Res (2): 225–256, 1982.Google Scholar
  32. 32.
    Hall RR, Schade R0K, Swinney J: Effects of hyperthermia on bladder cancer. Br J Urol (2): 593–594, 1974.Google Scholar
  33. 33.
    England HR, Anderson JD, Minasian H, Marshall VR, Molland EA, Blandy JP: The therapeutic application of hyperthermia in the bladder. Br J Urol (47): 849–851, 1975.Google Scholar
  34. 34.
    Rege VB, Leone LA, Soderberg CH Jr, Coleman GV, Robidoux HJ, Fijman R, Brown J: Hyperthermic adjuvant perfusion chemotherapy for stage I malignant melanoma of the extremity with literature review. Cancer (52): 2033–2039, 1983.Google Scholar
  35. 35.
    Wile A, Juler GL, Rosenberg H, Haiouc Nf Stemmer EA: Control of pelvic cancer with hyperthermic isolation-perfusion. J Surg Res (34): 560–567, 1983.Google Scholar
  36. 36.
    Hall RR, Wadehra V, Towler JR, Hindmarsh JR, Byrne PO: Hyperthermia in the treatment of bladder tumours. Br J Urol (48): 603–608, 1976.Google Scholar
  37. 37.
    Shingelton WW, Parker RT, Mahaley S: Abdominal perfusion for cancer chemotherapy with hypothermia and hyperthermia. Surgery (50): 260–265, 1961.Google Scholar
  38. 38.
    Spratt JS, Adcock RA, Sherrill W, Travathon S: Hyperthermic peritoneal perfusion system in canines. Cancer Res (40): 253–255, 1980.Google Scholar
  39. 39.
    Spratt JS, Adcock RA, Muskovin M, Sherrill W, McKeown J: Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res (40): 256: 260, 1980.PubMedGoogle Scholar
  40. 40.
    Shiu MH, Fortner JG: Intraperitoneal hyperthermic treatment of implanted peritoneal cancer in rats. Cancer Res (40): 4081–4084, 1980.PubMedGoogle Scholar
  41. 41.
    Hume SP, Marigold JCL, Michalowski A: The effect of local hyperthermia on nonproliferative, compared with proliferative, epithelial cells of mouse intestinal mucosa. Radiat Res (94)252–262, 1983.PubMedCrossRefGoogle Scholar
  42. 42.
    Jain RK: Bioheat transfer: Mathematical models of thermal systems. In: Storm FK (ed) Hyperthermia in cancer therapy. GK Hall, Boston, 1983, pp 9–46.Google Scholar
  43. 43.
    Christensen DA: Thermometry and thermography. In: Storm FK (ed). Hyperthermia in cancer therapy. GK Hall, Boston, 1983, pp 223–232.Google Scholar
  44. 44.
    Jacobs SC, Lawson RK: Pathologic effects of pre-cystectomy therapy with combination intra-arterial doxorubicin hydrochloride and local bladder hyperthermia for bladder cancer. J Urol (127): 43–47, 1982.PubMedGoogle Scholar
  45. 45.
    Meshorer A, Prionas SD, Fajardo, LF, Meyer JL, Hahn GM, Martinez AA: The effects of hyperthermia on normal mesenchymal tissues. Arch Pathol Lab Med (107)328–334, 1983.PubMedGoogle Scholar
  46. 46.
    Bonnem EM, Litterst CL, Smith FP: Platinum concentrations in human glioblastoma multiforme following the use of cisplatin. Cancer Treat Rep (66): 1661–1663, 1983.Google Scholar
  47. 47.
    Litterst CL, LeRoy AF, Guarrino AM: Disposition and distribution of platinum following parenteral administration of cis-dichlorodiammine platinum (II) to animals. Cancer Treat Rep (63): 1485–1492, 1979.Google Scholar

Copyright information

© Martinus Nijhoff Publishers, Boston 1984

Authors and Affiliations

  • Stephen C. Jacobs

There are no affiliations available

Personalised recommendations